Flagship Harbor Advisors’s Usana Health Sciences USNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-38
Closed -$2.8K 1958
2019
Q3
$2K Sell
38
-293
-89% -$19.7K ﹤0.01% 1706
2019
Q2
$26K Sell
331
-417
-56% -$33.1K 0.01% 990
2019
Q1
$62K Buy
748
+71
+10% +$7.41K 0.01% 696
2018
Q4
$79K Buy
677
+256
+61% +$29.6K 0.02% 584
2018
Q3
$50K Buy
421
+287
+214% +$35.6K 0.01% 804
2018
Q2
$15K Buy
+134
New +$14.7K ﹤0.01% 1226

Other funds holding USNA

Flagship Harbor Advisors's USNA Position: Q4 2019 in Review

Flagship Harbor Advisors sold out of Usana Health Sciences (USNA) in Q4 2019, closing a stake of 38 shares — an estimated $2.8K sold.

Flagship Harbor Advisors first reported a position in USNA in Q2 2018 and held it in 6 quarters. The position peaked at $79K in Q4 2018. 175 funds tracked by Wall St. Rank hold USNA as of Q4 2019.

  • Flagship Harbor Advisors reported no remaining Usana Health Sciences position as of Q4 2019 after selling out during the quarter.
  • Flagship Harbor Advisors sold 38 Usana Health Sciences shares in Q4 2019, an estimated $2.8K.
  • Flagship Harbor Advisors first reported a position in Usana Health Sciences in Q2 2018 and held it in 6 quarters.
  • Flagship Harbor Advisors's Usana Health Sciences position peaked at $79K in Q4 2018.
  • 175 funds tracked by Wall St. Rank held Usana Health Sciences as of Q4 2019.

Based on Flagship Harbor Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.